Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 1
2014 2
2017 3
2018 4
2019 11
2020 11
2021 5
2022 3
2023 3
2024 5
2025 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

48 results

Results by year

Filters applied: . Clear all
Page 1
Multidrug-resistant tuberculosis.
Chiang CY, Van Deun A, Trébucq A, Piubello A, Schwoebel V, Rieder HL. Chiang CY, et al. Among authors: piubello a. Lancet. 2019 Jul 27;394(10195):299. doi: 10.1016/S0140-6736(19)30046-7. Lancet. 2019. PMID: 31354138 No abstract available.
QTc and anti-tuberculosis drugs: a perfect storm or a tempest in a teacup? Review of evidence and a risk assessment.
Monedero-Recuero I, Hernando-Marrupe L, Sánchez-Montalvá A, Cox V, Tommasi M, Furin J, Chiang CY, Quelapio M, Koura KG, Trébucq A, Padanilam X, Dravniece G, Piubello A. Monedero-Recuero I, et al. Among authors: piubello a. Int J Tuberc Lung Dis. 2018 Oct 26. doi: 10.5588/ijtld.18.0423. Online ahead of print. Int J Tuberc Lung Dis. 2018. PMID: 30366516
Management of individuals exposed to multidrug-resistant or rifampicin-resistant tuberculosis.
Seddon JA, Achar J, Malik AA, Hughes J, Burzynski J, Chen C, Denholm JT, Dravniece G, Fox GJ, Furin J, Geliukh E, Goncharova O, Guglielmetti L, Harries AD, Hesseling AC, Nguyen BH, Kavenga F, Khan U, Kherabi Y, Kiria N, Kock Y, Liu Q, Mesic A, Moore DAJ, Mubanga A, Naidoo L, Nilsen D, Piubello A, Reuter A, Rich ML, Satyanarayana S, Schaaf HS, Schoeman I, Skrahina A, Udwadia Z, Khan PY, Esmail H, Martinez L. Seddon JA, et al. Among authors: piubello a. Lancet Infect Dis. 2025 Dec;25(12):e692-e704. doi: 10.1016/S1473-3099(25)00157-4. Epub 2025 Jun 6. Lancet Infect Dis. 2025. PMID: 41036784 Review.
Safety, effectiveness, and adherence of a short and all-oral treatment regimen for the treatment of rifampicin-resistant tuberculosis in Niger: a study protocol of a pragmatic randomised clinical trial with stratified block randomisation.
Souleymane MB, Decroo T, Soumana A, Maman Lawan I, Gagara-Issoufou A, Halidou-Moussa S, Ortuño-Gutiérrez N, Adehossi E, Mamadou S, Van Deun A, Piubello A. Souleymane MB, et al. Among authors: piubello a. Trials. 2022 Dec 13;23(1):1011. doi: 10.1186/s13063-022-06912-7. Trials. 2022. PMID: 36514153 Free PMC article.
Treatment outcome with a short multidrug-resistant tuberculosis regimen in nine African countries.
Trébucq A, Schwoebel V, Kashongwe Z, Bakayoko A, Kuaban C, Noeske J, Hassane S, Souleymane B, Piubello A, Ciza F, Fikouma V, Gasana M, Ouedraogo M, Gninafon M, Van Deun A, Cirillo DM, Koura KG, Rieder HL. Trébucq A, et al. Among authors: piubello a. Int J Tuberc Lung Dis. 2018 Jan 1;22(1):17-25. doi: 10.5588/ijtld.17.0498. Epub 2017 Nov 17. Int J Tuberc Lung Dis. 2018. PMID: 29149917
48 results